M
Marisa B. Marques
Researcher at University of Alabama at Birmingham
Publications - 205
Citations - 7431
Marisa B. Marques is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Thrombotic thrombocytopenic purpura & Blood transfusion. The author has an hindex of 37, co-authored 195 publications receiving 6410 citations. Previous affiliations of Marisa B. Marques include Brigham and Women's Hospital & University of Alabama.
Papers
More filters
Journal ArticleDOI
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
Jeffrey L. Carson,Brenda J. Grossman,Steven Kleinman,Alan Tinmouth,Marisa B. Marques,Mark K. Fung,John B. Holcomb,Orieji Illoh,Lewis J. Kaplan,Louis M. Katz,Sunil V. Rao,John D. Roback,Aryeh Shander,Robert Weinstein,Lisa Grace,Swinton McLaughlin,Benjamin Djulbegovic +16 more
TL;DR: The AABB developed this guideline to provide clinical recommendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children.
Journal ArticleDOI
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury
Axelle Caudrillier,Kai Kessenbrock,Brian M. Gilliss,John X. Nguyen,Marisa B. Marques,Marc Monestier,Pearl Toy,Zena Werb,Mark R. Looney +8 more
TL;DR: It is reported that activated platelets induce the formation of neutrophil extracellular traps (NETs) in transfusion-related acute lung injury (TRALI), which is the leading cause of death after transfusion therapy.
Journal ArticleDOI
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Zbigniew M. Szczepiorkowski,Jeffrey L. Winters,Nicholas Bandarenko,Haewon C. Kim,Michael L. Linenberger,Marisa B. Marques,Ravindra Sarode,Joseph E. Schwartz,Robert Weinstein,Beth H. Shaz +9 more
TL;DR: The Fourth ASFA Special Issue is significantly modified in comparison to the previous editions and a new concept of a fact sheet has been introduced that succinctly summarizes the evidence for the use of therapeutic apheresis.
Journal ArticleDOI
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi,Shelley Hurwitz,Shelley Hurwitz,Ashley Fry,Marisa B. Marques,Stephen W. Waldo,Ang Li,Lova Sun,Vivek A. Upadhyay,Ayad Hamdan,Ayad Hamdan,Andrew M. Brunner,John M. Gansner,John M. Gansner,Srinivas R. Viswanathan,Richard M. Kaufman,Richard M. Kaufman,Lynne Uhl,Lynne Uhl,Christopher P. Stowell,Walter H. Dzik,Robert S. Makar +21 more
TL;DR: A seven-component clinical prediction tool, termed the PLASMIC score, was developed and found to reliably assess the pretest probability of severe ADAMTS13 deficiency, and it is shown that this scoring system is superior to standard clinical assessment in addressing the diagnostic challenge presented by thrombotic microangiopathy.
Journal ArticleDOI
Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
TL;DR: It is concluded that the sialylated type III capsular polysaccharide inhibits alternative-pathway activation, prevents C3 deposition on group B streptococci, and protects the organisms from phagocytic killing.